Cargando…
Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa
BACKGROUND: The transglutaminase activated factor XIII (FXIIIa) acts to strengthen pathological fibrin clots and to slow their dissolution, in part by crosslinking active α(2)-antiplasmin (α(2)AP) to fibrin. We previously reported that a yeast-derived recombinant fusion protein comprising α(2)AP res...
Autores principales: | Sheffield, William P, Eltringham-Smith, Louise J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258216/ https://www.ncbi.nlm.nih.gov/pubmed/22185689 http://dx.doi.org/10.1186/1472-6750-11-127 |
Ejemplares similares
-
Addition of a sequence from α(2)-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
por: Sheffield, William P, et al.
Publicado: (2009) -
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss
por: Sheffield, William P., et al.
Publicado: (2018) -
Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
por: Porrello, Alessandro, et al.
Publicado: (2018) -
Endotoxin enhances the fibrinolytic activity of monocytes incorporated in a fibrin clot
por: Grosjean, A, et al.
Publicado: (2005) -
Ethacrynic acid is an inhibitor of human factor XIIIa
por: Kar, Srabani, et al.
Publicado: (2022)